Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 03, 2025

Get In Touch

Wockhardt posts profit of Rs 82 crore in Q2 Pharma News

Wockhardt posts profit of Rs 82 crore in Q2

  • 03 November 2025
  • 1 hour from now

Wockhardt seeks USFDA approval for Zidebactam-Cefepime injection to treat Serious GramNegative Infections Pharma News

Wockhardt seeks USFDA approval for Zidebactam-Cefepime injection to treat Serious GramNegative Infections

  • 01 October 2025
  • 1 month ago

CDSCO Panel Asks Wockhardt to Revise Phase III Study Protocol for Nafithromycin, Seeks Dosing, Control Arm Changes Pharma News

CDSCO Panel Asks Wockhardt to Revise Phase III Study Protocol for Nafithromycin, Seeks Dosing, Control Arm Changes

  • 16 September 2025
  • 1 month ago

Shukra Pharma wins rights to distribute Wockhardt advanced anti-infective formulations across India Pharma News

Shukra Pharma wins rights to distribute Wockhardt advanced anti-infective formulations across India

  • 11 September 2025
  • 1 month ago

Wockhardt Secures CDSCO Panel Conditional Nod To Conduct Phase IV Trial Of Levonadifloxacin Delhi

Wockhardt Secures CDSCO Panel Conditional Nod To Conduct Phase IV Trial Of Levonadifloxacin

  • 14 July 2025
  • 3 months ago

Recent News

Nanotechnology Reverses Alzheimer's Symptoms in Mi...

  • 03 November, 2025

Gum disease could silently cause serious brain dam...

  • 03 November, 2025

Can Early-Day Fasting Significantly Boost Metaboli...

  • 03 November, 2025

Delhi HC bars doctor from running medical centre d...

  • 03 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.